Co-existence of relapsing polychondritis and Crohn disease treated successfully with infliximab / 영남의대학술지
Yeungnam University Journal of Medicine
;
: 70-73, 2021.
Article
in English
| WPRIM
| ID: wpr-875567
ABSTRACT
Relapsing polychondritis (RP) is a rare, progressive immune-mediated systemic inflammatory disease of unknown etiology, characterized by recurrent inflammation of cartilaginous structures. Approximately 30% of RP cases are associated with other autoimmune diseases. However, the co-occurrence of RP and Crohn disease (CD) has rarely been reported. Herein, we present a 35-year-old woman diagnosed with RP and CD, who was refractory to initial conventional medications, including azathioprine and glucocorticoid, but who subsequently responded to infliximab (IFX). For both diseases, remission was sustained with IFX. There has been no previous report regarding the successful treatment of co-existing RP and CD with IFX.
Full text:
Available
Index:
WPRIM (Western Pacific)
Language:
English
Journal:
Yeungnam University Journal of Medicine
Year:
2021
Type:
Article
Similar
MEDLINE
...
LILACS
LIS